184 related articles for article (PubMed ID: 20346578)
1. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy.
Lindner U; Lawrentschuk N; Weersink RA; Davidson SR; Raz O; Hlasny E; Langer DL; Gertner MR; Van der Kwast T; Haider MA; Trachtenberg J
Eur Urol; 2010 Jun; 57(6):1111-4. PubMed ID: 20346578
[TBL] [Abstract][Full Text] [Related]
2. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer.
Raz O; Haider MA; Davidson SR; Lindner U; Hlasny E; Weersink R; Gertner MR; Kucharczyk W; McCluskey SA; Trachtenberg J
Eur Urol; 2010 Jul; 58(1):173-7. PubMed ID: 20334965
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
[TBL] [Abstract][Full Text] [Related]
4. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
[TBL] [Abstract][Full Text] [Related]
5. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
Lepor H; Llukani E; Sperling D; Fütterer JJ
Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
[TBL] [Abstract][Full Text] [Related]
6. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
7. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.
Djavan B; Zlotta AR; Susani M; Heinz G; Shariat S; Silverman DE; Schulman CC; Marberger M
Urology; 1997 Dec; 50(6):986-92; discussion 992-3. PubMed ID: 9426739
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.
Knull E; Oto A; Eggener S; Tessier D; Guneyli S; Chatterjee A; Fenster A
Med Phys; 2019 Feb; 46(2):800-810. PubMed ID: 30447155
[TBL] [Abstract][Full Text] [Related]
10. Role of MRI in minimally invasive focal ablative therapy for prostate cancer.
Rosenkrantz AB; Scionti SM; Mendrinos S; Taneja SS
AJR Am J Roentgenol; 2011 Jul; 197(1):W90-6. PubMed ID: 21701001
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
Anttinen M; Mäkelä P; Suomi V; Kiviniemi A; Saunavaara J; Sainio T; Horte A; Eklund L; Taimen P; Sequeiros RB; Boström PJ
Scand J Urol; 2019 Oct; 53(5):295-302. PubMed ID: 31556779
[No Abstract] [Full Text] [Related]
12. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C
Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
[TBL] [Abstract][Full Text] [Related]
13. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
[TBL] [Abstract][Full Text] [Related]
14. Topographical sensitivity and specificity of endorectal coil magnetic resonance imaging for prostate cancer detection.
Colleselli D; Schilling D; Lichy MP; Hennenlotter J; Vogel UH; Krueger SA; Kuehs U; Schlemmer HP; Stenzl A; Schwentner C
Urol Int; 2010; 84(4):388-94. PubMed ID: 20332606
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
[TBL] [Abstract][Full Text] [Related]
16. Image guided photothermal focal therapy for localized prostate cancer: phase I trial.
Lindner U; Weersink RA; Haider MA; Gertner MR; Davidson SR; Atri M; Wilson BC; Fenster A; Trachtenberg J
J Urol; 2009 Oct; 182(4):1371-7. PubMed ID: 19683262
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
[TBL] [Abstract][Full Text] [Related]
18. [Locoregional staging of prostatic carcinoma: accuracy of magnetic resonance with endorectal coil in 75 patients treated with radical prostatectomy].
Gualdi GF; Casciani E; Ferriano MG; Polettini E
Radiol Med; 1998 May; 95(5):498-505. PubMed ID: 9687928
[TBL] [Abstract][Full Text] [Related]
19. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
Wefer AE; Hricak H; Vigneron DB; Coakley FV; Lu Y; Wefer J; Mueller-Lisse U; Carroll PR; Kurhanewicz J
J Urol; 2000 Aug; 164(2):400-4. PubMed ID: 10893595
[TBL] [Abstract][Full Text] [Related]
20. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
